Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-induced Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Not applicableNot Yet RecruitingNCT07575854
What this trial is testing

Selective Internal Radiation Therapy for the Management of Chemotherapy-induced Thrombocytopenia With Splenomegaly in Adult Subjects With Gastrointestinal Cancer

Who this might be right for
Gastrointestinal Cancer
Centre Georges Francois Leclerc 18
Testing effectiveness (Phase 2)UnknownNCT05969158
What this trial is testing

Hetrombopag in Secondary Prevention of XPO-1 Inhibitor-induced Thrombocytopenia in Lymphoma

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
Sun Yat-sen University 90
Early research (Phase 1)Study completedNCT06521931
What this trial is testing

PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients

Who this might be right for
Thrombocytopenia
Chongqing Peg-Bio Biopharm Co., Ltd. 24
Post-approval studies (Phase 4)UnknownNCT03633019
What this trial is testing

High-dose Use of rhTPO in CIT Patients

Who this might be right for
Thrombocytopenia
First Affiliated Hospital Xi'an Jiaotong University 50
Early research (Phase 1)Study completedNCT00359463
What this trial is testing

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 33
Testing effectiveness (Phase 2)Looking for participantsNCT05236582
What this trial is testing

Herombopag for Chemotherapy-induced Thrombocytopenia

Who this might be right for
Chemotherapy-induced ThrombocytopeniaHerombopag
Institute of Hematology & Blood Diseases Hospital, China 50
Not applicableUnknownNCT02344979
What this trial is testing

The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC

Who this might be right for
Thrombocytopenia
Shenyang Sunshine Pharmaceutical Co., LTD. 120
Testing effectiveness (Phase 2)Study completedNCT02052882
What this trial is testing

Study of Romiplostim for Chemotherapy Induced Thrombocytopenia

Who this might be right for
Isolated Chemotherapy-induced Thrombocytopenia
Memorial Sloan Kettering Cancer Center 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07252375
What this trial is testing

A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)CTIT-Chemotherapy Induced Thrombocytopenia
Fujian Cancer Hospital 35
Testing effectiveness (Phase 2)Ended earlyNCT04671901
What this trial is testing

Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, ChildhoodSolid Carcinoma
Memorial Sloan Kettering Cancer Center 2
Large-scale testing (Phase 3)WithdrawnNCT03343847
What this trial is testing

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma.

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Amgen
Large-scale testing (Phase 3)UnknownNCT06201663
What this trial is testing

Romiplostim in Chemotherapy-Induced Thrombocytopenia

Who this might be right for
Chemotherapy-induced ThrombocytopeniaSolid Malignancy
Ain Shams University 30
Not applicableNot Yet RecruitingNCT07185893
What this trial is testing

A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors

Who this might be right for
Solid Tumor Malignancies, CancerCTIT-Chemotherapy Induced ThrombocytopeniaThrombocytopenia
Jun wang 106
Large-scale testing (Phase 3)Study completedNCT05554913
What this trial is testing

Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Qilu Pharmaceutical Co., Ltd. 63
Testing effectiveness (Phase 2)UnknownNCT04797182
What this trial is testing

Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma

Who this might be right for
ThrombocytopeniaCytarabine Causing Adverse Effects in Therapeutic UseLymphoma
Sun Yat-sen University 46
Testing effectiveness (Phase 2)UnknownNCT02781155
What this trial is testing

Limiting Chemotherapy Side Effects by Using Moxa

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsGenital Neoplasms, Female+1 more
East and North Hertfordshire NHS Trust 25
Large-scale testing (Phase 3)Active Not RecruitingNCT05864014
What this trial is testing

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 213
Not applicableStudy completedNCT01933035
What this trial is testing

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

Who this might be right for
Immune ThrombocytopeniaChemotherapy Induced ThrombocytopeniaMyelodysplasia+1 more
Beth Israel Medical Center 50
Testing effectiveness (Phase 2)Ended earlyNCT00886743
What this trial is testing

Study Evaluating The Effects Of Oprelvekin On Cardiac Repolarization In Subjects With Chemotherapy Induced Thrombocytopenia

Who this might be right for
Severe Thrombocytopenia
Pfizer 19